<a href="https://laohu8.com/S/WGRX">Wellgistics Health Inc.</a> Announces $5 Million Public Offering of Common Stock and Warrants
Wellgistics Health Inc. (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, has announced the pricing of a $5 million public offering. The offering consists of 7,142,862 shares of common stock, together with warrants to purchase an equal number of shares at a combined price of $0.70 per share and associated warrant. The warrants are immediately exercisable at $0.70 per share and will expire five years from the date of issuance. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. Wellgistics Health intends to use the net proceeds for working capital and general corporate purposes, which may include operating expenses, research and development, and potential acquisitions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016562), on October 01, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.